AskNiveshClosed·16:41 IST
  • Stocks
  • ·
  • Funds
  • ·
  • Signals

AskNivesh is a research desk for Indian markets, US equities, fund data, and disclosure trails. Built for investors who want source-backed context without the noise.

Market

  • Overview
  • Stocks
  • Indexes
  • Sectors
  • ETFs
  • Funds
  • IPOs

US Market

  • Political Trades
  • Disclosure Leaderboard
  • Politicians
  • Consensus Trades
  • Late Disclosures
  • Sector Tilt
  • US Stocks

Market Pulse

  • Market Pulse
  • Global Markets
  • Signals
  • FII DII Activity
  • Corporate Actions
  • RBI Macro
  • Derivatives
  • Currency Derivatives
  • Index Derivatives
  • Commodity Derivatives
  • F&O Expiries

Data

  • Glossary
  • Methodology
  • Analysis Methods
  • Technical Analysis
  • Candle Patterns
  • Brokers
  • Depositories
  • SEBI Intermediaries
  • Exchange Holidays
  • Global Investing
  • Sitemap

Company

  • About Us
  • Contact

Legal

  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
  • Methodology
  • ·Glossary
  • ·Sitemap
  • ·Contact
Browse stocks by letter
AllABCDEFGHIJKLMNOPQRSTUVWXYZOthers

Research and education only. Not investment advice under SEBI (IA) Regulations 2013, not a research report under SEBI (RA) Regulations 2014. Not a SEBI-registered Adviser, Analyst, or distributor.

AskNivesh©2026
asknivesh.com
← Back to DRREDDY

Dr. Reddy's Laboratories Ltd.: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

ParticularsMar-25Jun-25Sep-25Dec-25Mar-26
Revenue
8,5288,5728,8288,7537,546
Other income
522290324269475
Segment revenue (incl. inter-segment)
8,5288,5728,8288,7537,546
Expenses
7,0516,9587,4147,4817,827
Cost of materials consumed
1,7162,0361,4411,8261,199
Purchases of stock-in-trade
1,1281,2161,7461,5421,658
Change in inventories
6-444-64-272356
Employee benefit expense
1,4011,5041,4521,5881,447
Finance costs
66839194106
Depreciation & amortisation
455476505521557
Other expenses
2,2802,0882,2432,1822,504
EBITDA
2,5212,4642,3342,156858
EBIT
2,0661,9881,8291,635301
Operating profit
4,7274,8634,8144,6813,369
Profit Before Tax
2,0001,9051,7381,541195
Tax expense
418495408354-22
Deferred tax
-14-5312231462
Net Profit
1,5871,4101,3371,190221
Financial Ratios
Operating Profit Margin
55.43%56.73%54.53%53.48%44.65%
EBITDA Margin
29.56%28.74%26.44%24.64%11.37%
Net Profit Margin
18.61%16.45%15.14%13.60%2.93%
Earnings Per Share (₹)
19.1217.0416.1814.532.65

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.